Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.54 USD | -2.75% | -4.09% | +27.40% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.40% | 204M | |
+3.27% | 108B | |
+10.37% | 105B | |
+1.57% | 23.46B | |
-12.83% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-7.41% | 17.19B | |
+5.88% | 13.99B | |
+36.79% | 12.53B |
- Stock Market
- Equities
- ADVM Stock
- News Adverum Biotechnologies, Inc.
- Adverum Biotechnologies : Goldman Sachs Downgrades Adverum Biotechnologies to Neutral From Buy, Adjusts PT to $3 From $10